The role of peroxisome proliferator-activated receptor gamma in diabetes and obesity.

被引：63

作者：

Celi F.S. ^{[1
]}

Shuldiner A.R. ^{[1
]}

机构：

[1] University of Maryland School of Medicine, Division of Endocrinology, Diabetes and Nutrition, Room, 660 West Redwood Street, Baltimore, 21201, MD

来源：

Current Diabetes Reports | 2002年 / 2卷 / 2期

关键词：

Troglitazone; Retinoic Acid Receptor; Thyroid Hormone Receptor; Increase Insulin Sensitivity; Adipose Tissue Mass;

D O I：

10.1007/s11892-002-0078-2

中图分类号：

学科分类号：

摘要：

Peroxisome proliferator-activated receptor gamma (PPAR gamma) is a nuclear receptor, which upon activation with various natural and synthetic ligands, stimulates the transcription of genes responsible for growth and differentiation of adipocytes. Furthermore, PPAR gamma is the receptor for the insulin-sensitizing thiazolidinediones, which are commonly used for the treatment of type 2 diabetes. Rare inactivating mutations of the gene encoding PPAR gamma are associated with insulin resistance type 2 diabetes, and hypertension, whereas a rare gain of function mutation causes extreme obesity. A common polymorphism (Pro12Ala) of the adipose tissue-specific gamma 2 isoform is associated with increased insulin sensitivity and decreased risk of developing type 2 diabetes. These findings indicate a central role of PPAR gamma in fat cell biology and in the pathophysiology of obesity, diabetes, and insulin resistance.

引用

页码：179 / 185

页数：6

共 174 条

[1] Fruhbeck G(2001)The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation Am J Physiol Endocrinol Metab 280 E827-847
[2] Gomez-Ambrosi J(2001)Resistin, obesity, and insulin resistance—the emerging role of the adipocyte as an endocrine organ N Engl J Med 345 1345-1346
[3] Muruzabal FJ(1997)Congenital leptin deficiency is associated with severe early-onset obesity in humans Nature 387 903-908
[4] Burrell MA(1998)A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction Nature 392 330-331
[5] Shuldiner AR(2001)Regulation of leptin production Rev Endocr Metab Disord 2 357-363
[6] Yang R(1997)TNF-alpha-induced insulin resistance in vivo and its prevention by troglitazone Diabetes 46 1678-1683
[7] Gong D-W(1997)Role of fatty acids in the pathogenesis of insulin resistance and NIDDM Diabetes 46 3-10
[8] Montague CT(2001)The pleiotropic functions of peroxisome proliferator-activated receptor gamma J Mol Med 79 30-47
[9] Farooqi IS(2001)Peroxisome proliferatoractivated receptor-gamma: from adipogenesis to carcinogenesis J Mol Endocrinol 27 1-9
[10] Whitehead JP(1999)The peroxisome proliferator-activated receptor (PPARgamma) as a regulator of monocyte/macrophage function J Leukoc Biol 66 733-739

← 1 2 3 4 5 6 7 8 9 10 →